Christine Gebski, See Remarks at REPLIGEN CORP (RGEN), sold 1,400 shares at $196.88 ($276K) on 2021-03-16, disclosed to the SEC on 2021-03-18.
Open-market sale of $276k RGEN by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGEN | SELL | 2021-09-02 | $1.9M | — | Filing → |
| RGEN | SELL | 2021-05-18 | $153K | — | Filing → |